CDK4/6 Inhibitor PD 0332991 Sensitizes Acute Myeloid Leukemia to Cytarabine-Mediated Cytotoxicity

Cancer Research
Chenyi YangPengbo Zhou

Abstract

Cyclin-dependent kinase (CDK)4 and CDK6 are frequently overexpressed or hyperactivated in human cancers. Targeting CDK4/CDK6 in combination with cytotoxic killing therefore represents a rational approach to cancer therapy. By selective inhibition of CDK4/CDK6 with PD 0332991, which leads to early G1 arrest and synchronous S-phase entry upon release of the G1 block, we have developed a novel strategy to prime acute myeloid leukemia (AML) cells for cytotoxic killing by cytarabine (Ara-C). This sensitization is achieved in part through enrichment of S-phase cells, which maximizes the AML populations for Ara-C incorporation into replicating DNA to elicit DNA damage. Moreover, PD 0332991 triggered apoptosis of AML cells through inhibition of the homeobox (HOX)A9 oncogene expression, reducing the transcription of its target PIM1. Reduced PIM1 synthesis attenuates PIM1-mediated phosphorylation of the proapoptotic BAD and activates BAD-dependent apoptosis. In vivo, timely inhibition of CDK4/CDK6 by PD 0332991 and release profoundly suppresses tumor growth in response to reduced doses of Ara-C in a xenograft AML model. Collectively, these data suggest selective and reversible inhibition of CDK4/CDK6 as an effective means to enhance Ara-...Continue Reading

References

Feb 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H TillyL Degos
Jan 1, 1995·Pharmacology & Therapeutics·E S Arnér, S Eriksson
Jan 9, 2007·Current Opinion in Genetics & Development·Marcos Malumbres, Mariano Barbacid
Mar 1, 2007·Blood·Yu-Long HuHugh Jeffrey Lawrence
Dec 6, 2008·Blood·Joerg FaberScott A Armstrong
May 6, 2009·Journal of Cellular Physiology·Jong Kyong Kim, J Alan Diehl

❮ Previous
Next ❯

Citations

Dec 10, 2015·Nature Medicine·Lan WangStephen D Nimer
May 17, 2017·Expert Opinion on Emerging Drugs·Abdallah Abou Zahr, Gautam Borthakur
Oct 16, 2019·Expert Opinion on Investigational Drugs·Daniel J Lee, Joshua F Zeidner
Sep 27, 2019·Frontiers in Pediatrics·Michaela KuhlenJessica I Hoell
May 3, 2020·Journal of Hematology & Oncology·Qi DuQin Li
Apr 9, 2020·International Journal of Molecular Sciences·Iris Z UrasKaroline Kollmann
Jan 11, 2020·Frontiers in Oncology·Raoul Tibes, James M Bogenberger
Feb 6, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yana PikmanKimberly Stegmaier
Dec 23, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·William L CarrollElizabeth Raetz
Mar 26, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Allison R HanafordEric H Raabe
Jan 17, 2021·Journal of Cellular and Molecular Medicine·Xiaotong ZhangChuize Kong
Dec 1, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Ying XuRongzhen Xu
Dec 22, 2020·ACS Pharmacology & Translational Science·Alessandra MessikommerNathan W Luedtke
Jun 3, 2021·International Journal of Molecular Sciences·Guadalupe Rosario Fajardo-OrduñaEdelmiro Santiago-Osorio

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.